To further validate the action of MTEP on the mGlu5 receptor, mice were treated with a positive allosteric modulator (PAM) of mGluR5 VU036017244,45 daily starting 2 days after stroke and 1 h prior to MTEP treatment (Fig. 4A). Here, GRM5 is linked to stroke disorder.